TGFB1 and cancer: It was shown that the release of TGF‐β and FGF5 from CAFs causes myofibroblast reprogramming in cancer stem cells (CSCs), which is needed to protect the cells from external influences and to acquire a chemoresistance characteristic within the cells (94).